These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38848940)

  • 1. Survivin (BIRC5): Implications in cancer therapy.
    Siragusa G; Tomasello L; Giordano C; Pizzolanti G
    Life Sci; 2024 Aug; 350():122788. PubMed ID: 38848940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of SMAC with a survivin-derived peptide alters essential cancer hallmarks: Tumor growth, inflammation, and immunosuppression.
    Santhanam M; Kumar Pandey S; Shteinfer-Kuzmine A; Paul A; Abusiam N; Zalk R; Shoshan-Barmatz V
    Mol Ther; 2024 Jun; 32(6):1934-1955. PubMed ID: 38582961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells.
    Yang R; Liu M; Liang H; Guo S; Guo X; Yuan M; Lian H; Yan X; Zhang S; Chen X; Fang F; Guo H; Zhang C
    Mol Cancer; 2016 Dec; 15(1):82. PubMed ID: 27978829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of survivin in mitosis].
    Wolanin K; Piwocka K
    Postepy Biochem; 2007; 53(1):10-8. PubMed ID: 17718383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of role of survivin in cancer: expression, regulation, functions, and its potential as a therapeutic target.
    Fang XL; Cao XP; Xiao J; Hu Y; Chen M; Raza HK; Wang HY; He X; Gu JF; Zhang KJ
    J Drug Target; 2024 Dec; 32(3):223-240. PubMed ID: 38252514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring survivin expression in cancer: implications for prognosis and therapy.
    Santa Cruz Guindalini R; Mathias Machado MC; Garicochea B
    Mol Diagn Ther; 2013 Dec; 17(6):331-42. PubMed ID: 23912862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The survivin molecule as a double-edged sword in cellular physiologic and pathologic conditions and its role as a potential biomarker and therapeutic target in cancer.
    Rafatmanesh A; Behjati M; Mobasseri N; Sarvizadeh M; Mazoochi T; Karimian M
    J Cell Physiol; 2020 Feb; 235(2):725-744. PubMed ID: 31250439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells.
    Conde M; Michen S; Wiedemuth R; Klink B; Schröck E; Schackert G; Temme A
    BMC Cancer; 2017 Dec; 17(1):889. PubMed ID: 29282022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-214-3p modified tetrahedral framework nucleic acids target survivin to induce tumour cell apoptosis.
    Li S; Sun Y; Tian T; Qin X; Lin S; Zhang T; Zhang Q; Zhou M; Zhang X; Zhou Y; Zhao H; Zhu B; Cai X
    Cell Prolif; 2020 Jan; 53(1):e12708. PubMed ID: 31642557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients.
    Hmeljak J; Erčulj N; Dolžan V; Kern I; Cör A
    J Cancer Res Clin Oncol; 2011 Nov; 137(11):1641-51. PubMed ID: 21861135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy.
    Wang S; Xu Y; Chan HF; Kim HW; Wang Y; Leong KW; Chen M
    J Control Release; 2016 Oct; 240():454-464. PubMed ID: 27091696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting survivin in cancer: the cell-signalling perspective.
    Kanwar JR; Kamalapuram SK; Kanwar RK
    Drug Discov Today; 2011 Jun; 16(11-12):485-94. PubMed ID: 21511051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.
    Augello C; Caruso L; Maggioni M; Donadon M; Montorsi M; Santambrogio R; Torzilli G; Vaira V; Pellegrini C; Roncalli M; Coggi G; Bosari S
    BMC Cancer; 2009 Apr; 9():125. PubMed ID: 19397802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR‑203 regulates the proliferation, apoptosis and cell cycle progression of pancreatic cancer cells by targeting Survivin.
    Xu D; Wang Q; An Y; Xu L
    Mol Med Rep; 2013 Aug; 8(2):379-84. PubMed ID: 23732815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trace of survivin in cancer.
    Shojaei F; Yazdani-Nafchi F; Banitalebi-Dehkordi M; Chehelgerdi M; Khorramian-Ghahfarokhi M
    Eur J Cancer Prev; 2019 Jul; 28(4):365-372. PubMed ID: 29847456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is survivin the potential Achilles' heel of cancer?
    Lladser A; Sanhueza C; Kiessling R; Quest AF
    Adv Cancer Res; 2011; 111():1-37. PubMed ID: 21704829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of the survivin gene.
    Boidot R; Végran F; Lizard-Nacol S
    Mol Biol Rep; 2014 Jan; 41(1):233-40. PubMed ID: 24197699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Old Flame Never Dies: Survivin in Cancer and Cellular Senescence.
    Unruhe B; Schröder E; Wünsch D; Knauer SK
    Gerontology; 2016; 62(2):173-81. PubMed ID: 26159786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibitors of apoptosis (IAPs) and their emerging role in cancer.
    LaCasse EC; Baird S; Korneluk RG; MacKenzie AE
    Oncogene; 1998 Dec; 17(25):3247-59. PubMed ID: 9916987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BIRC5/Survivin is a novel ATG12-ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells.
    Lin TY; Chan HH; Chen SH; Sarvagalla S; Chen PS; Coumar MS; Cheng SM; Chang YC; Lin CH; Leung E; Cheung CHA
    Autophagy; 2020 Jul; 16(7):1296-1313. PubMed ID: 31612776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.